Anti-tumor efficacy of 0114 blockade in combination with sunitinib or aflibercept in primary human renal cell carcinoma models

被引：0
|
作者：
Miles, Kiersten Marie [1 ]
Gillard, Bryan [1 ]
Kuhnert, Frank [2 ]
Thurston, Gavin [2 ]
Lalani, Alshad S. [2 ]
Pili, Roberto [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[2] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2329
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2329
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models
    Zheng, Li-mou
    Li, Zujin
    Liu, Lanzhen
    Song, Bai Louis
    King, Ivan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 45 - 51
  • [22] Response of the Primary Tumor to Neoadjuvant Sunitinib in Patients With Advanced Renal Cell Carcinoma COMMENT
    Shuch, Brian
    Belldegrun, Arie
    JOURNAL OF UROLOGY, 2009, 181 (02): : 523 - 523
  • [23] Anti-tumor efficacy of human anti-c-met CAR-T cells against papillary renal cell carcinoma in an orthotopic model
    Mori, Jun-ich
    Adachi, Keishi
    Sakoda, Yukimi
    Sasaki, Takahiro
    Goto, Shunsuke
    Matsumoto, Hiroaki
    Nagashima, Yoji
    Matsuyama, Hideyasu
    Tamada, Koji
    CANCER SCIENCE, 2021, 112 (04) : 1417 - 1428
  • [24] Anti-tumor activity of motesanib diphosphate alone and in combination with docetaxel or tamoxifen in xenograft models of human breast carcinoma
    Coxon, A.
    Bush, T.
    Belmontes, B.
    Suffran, D.
    Ona, V
    Rex, K.
    Caenepeel, S.
    Hughes, P.
    Koifnon, S.
    Radinsky, R.
    Kendall, R.
    Price, J.
    Polverino, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S77 - S77
  • [25] Enhanced anti-tumor response to anti-angiogenic/hypoxia-regulating therapies in combination with immune checkpoint blockade in a murine model of renal carcinoma
    Chaibi, Assia
    Rey, Christophe
    Bessede, Alban
    Nafia, Imane
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [26] Corticosteroid premedication on anti-tumor effect of immune checkpoint blockade in murine hepatocellular carcinoma models
    Shen, Ying-Chun
    Chang, Nai-Wen
    Yeh, Ching-Ping
    Lin, Wan-Ying
    Wei, Ming-Feng
    Ou, Da-Liang
    Hsu, Chia-Lang
    Cheng, Ann-Lii
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
  • [27] Evaluation of safety, tolerability and anti-tumor efficacy of Temsirolimus in patients with advanced or metastatic renal cell carcinoma (a/mRCC)
    Kuhn, S.
    Krekeler, G.
    Bergmann, L.
    Roigas, J.
    Steiner, T.
    Kalanovic, D.
    ONKOLOGIE, 2011, 34 : 181 - 181
  • [28] ANTI-TUMOR EFFECTS OF PARTIALLY PURE HUMAN-LEUKOCYTE INTERFERON IN RENAL-CELL CARCINOMA
    QUESADA, JR
    GUTTERMAN, JU
    SWANSON, D
    TRINDADE, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 143 - 143
  • [29] Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade
    Liu, Xiaowei
    Feng, Yanlin
    Xu, Jie
    Shi, Ying
    Yang, Jiqiao
    Zhang, Rongjie
    Song, Jinen
    Bai, Xin
    Wu, Xi
    Bao, Yu
    Luo, Ya
    Li, Huifang
    Chai, Li
    Gong, Changyang
    Wang, Yan
    Chen, Bo
    Hu, Jianping
    Fu, Yan
    Luo, Yongzhang
    Zhang, Haiyuan
    Shi, Hubing
    JOURNAL OF CONTROLLED RELEASE, 2021, 332 : 194 - 209
  • [30] Anti-angiogenic efficacy of aflibercept and bevacizumab in primary oral squamous cell carcinoma cells
    Ganjibakhsh, Meysam
    Monshizadeh, Roshanak
    Nasimian, Ahmad
    Aminishakib, Pouyan
    Farzaneh, Parvaneh
    Shiraji, Sahar Tavakoli
    Gharajei, Ata
    Rahrotaban, Sedigheh
    Baghaei, Fereshteh
    Gohari, Neda Sadat
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2018, 47 (06) : 575 - 582
12345